title: Control of porcine reproductive and respiratory syndrome (PRRS) through genetic improvements in disease resistance and tolerance.
abstract: Infections caused by porcine reproductive and respiratory syndrome virus (PRRSV) have a severe economic impact on pig production in North America, Europe, and Asia. The emergence and eventual predominance of PRRS in the 1990s are the likely result of changes in the pork industry initiated in the late 1970s, which allowed the virus to occupy a unique niche within a modern commercial production system. PRRSV infection is responsible for severe clinical disease, but can maintain a life-long subclinical infection, as well as participate in several polymicrobial syndromes. Current vaccines lessen clinical signs, but are of limited use for disease control and elimination. The relatively poor protective immunity following vaccination is a function of the virus's capacity to generate a large degree of genetic diversity, combined with several strategies to evade innate and adaptive immune responses. In 2007, the PRRS Host Genetics consortium (PHGC) was established to explore the role of host genetics as an avenue for PRRS control. The PHGC model for PRRS incorporates the experimental infection of large numbers of growing pigs and has created the opportunity to study experimental PRRSV infection at the population level. The results show that pigs can be placed into distinct phenotypic groups, including pigs that show resistance (i.e., low virus load) or pigs that exhibit "tolerance" to infection. Tolerance was illustrated by pigs that gain weight normally in the face of a relatively high virus load. Genome-wide association analysis has identified a region on chromosome 4 (SSC4) correlated with resistance; i.e., lower cumulative virus load within the first 42 days of infection. The genomic region is near a family of genes involved in innate immunity. The region is also associated with higher weight gain in challenged pigs, suggesting that pigs with the resistance alleles don't seem to simultaneously experience reduction in growth, i.e., that resistance and tolerance are not antagonistically related. These results create the opportunity to develop breeding programs that will produce pigs with increased resistance to PRRS and simultaneously high growth rate. The identification of genomic markers involved in actual tolerance will likely prove more difficult, primarily because tolerance is difficult to quantify and because tolerance mechanism are still poorly understood. Another avenue of study includes the identification of genomic markers related to improved response following vaccination.
authors: Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University Manhattan, KS, USA.
authors: Raymond R R
authors: RR
authors: Rowland
authors: Joan
authors: J
authors: Lunney
authors: Jack
authors: J
authors: Dekkers
keywords: PRRS resistance; genome-wide association study; porcine reproductive and respiratory syndrome
references: J Interferon Cytokine Res. 2011 Jan;31(1):89-97
references: 21142871
references: Emerg Infect Dis. 2007 Sep;13(9):1434-6
references: 18252136
references: Springer Semin Immunopathol. 1995;17(2-3):167-86
references: 8571167
references: Virus Res. 2010 Dec;154(1-2):114-22
references: 20832434
references: Arch Virol. 2007;152(5):1009-17
references: 17323198
references: Front Genet. 2012 Dec 14;3:265
references: 23412990
references: J Anim Sci. 2007 Sep;85(9):2075-92
references: 17468430
references: Vaccine. 2011 Oct 26;29(46):8192-204
references: 21925560
references: J Anim Sci. 2012 Jun;90(6):1733-46
references: 22205662
references: Virus Res. 2010 Dec;154(1-2):1-6
references: 20951175
references: BMC Vet Res. 2010 Jun 04;6:30
references: 20525333
references: J Anim Sci. 2009 May;87(5):1638-47
references: 19181772
references: J Anim Sci. 2005 Jul;83(7):1494-502
references: 15956456
references: J Anim Sci. 2009 Mar;87(3):876-84
references: 18952741
references: J Vet Diagn Invest. 1992 Apr;4(2):127-33
references: 1616976
references: Antiviral Res. 2004 Jul;63(1):15-24
references: 15196816
references: J Gen Virol. 2011 May;92(Pt 5):1107-1116
references: 21307222
references: Virus Res. 2010 Dec;154(1-2):161-9
references: 20709118
references: Curr Opin Virol. 2012 Jun;2(3):256-63
references: 22709514
references: J Gen Virol. 1994 May;75 ( Pt 5):1071-81
references: 8176369
references: J Anim Breed Genet. 2010 Apr;127(2):100-6
references: 20433517
references: Science. 2009 Jul 10;325(5937):204-6
references: 19590002
references: J Anim Sci. 2000 Oct;78(10):2690-5
references: 11048935
references: Vet Microbiol. 2002 May 1;86(3):213-28
references: 11900956
references: J Anim Sci. 2006 Jan;84(1):49-57
references: 16361491
references: Genet Res (Camb). 2011 Aug;93(4):291-302
references: 21767462
references: Vet Microbiol. 2003 Oct 30;96(3):219-35
references: 14559170
references: J Am Vet Med Assoc. 2005 May 15;226(10):1707-11
references: 15906573
references: Virus Res. 2010 Dec;154(1-2):141-9
references: 20655962